Antiplatelet Activity of KR-32558, a Novel Selective Sodium/hydrogen Exchanger-1 Inhibitor

  • Lee, Mi-Yea (College of Social Sciences, Cheongju University) ;
  • Yun, Yeo-Pyo (College of Pharmacy, Chungbuk National University)
  • 발행 : 2004.09.01

초록

We investigated the antiplatelet effect of a newly synthesized guanidine derivative KR-32558, a sodium-hydrogen exchanger-1 (NHE-1) inhibitor, together with the elucidation of the possible mechanisms of action. KR-32558 concentration -dependently inhibited the aggregation of washed rabbit platelets induced by collagen (10 ${\mu}g/ml$) with an $IC_{50}$ value of 85.9 ${\mu}M$, but with much weaker potency against aggregation induced by thapsigargin (0.5 ${\mu}M$) or A23187 (5 ${\mu}M$). And had no effect on platelet aggregation induced by arachidonic acid (100 ${\mu}M$), thrombin (0.05 U/ml) and U46619 (1 ${\mu}M$) up to 100 ${\mu}M$. KR-32558 completely inhibited the $[Ca^{2+}]_i$ mobilization induced by collagen at concentration of 100${\mu}iM$. Taken together, these observation suggest that KR-32558 selectively inhibited collagen-mediated platelet aggregation by blocking the cytoplasmic calcium mobilization in addition to NHE-1 inhibition.

키워드

참고문헌

  1. Born, G.Y. & Cross, M.J.: The aggregation of blood platelets. J. Physiol., 168, 178-195 (1963) https://doi.org/10.1113/jphysiol.1963.sp007185
  2. COLMAN, R, COOK, J. & NIEWIAROWSKl, S.: Hemostasis and thrombosis. J.B.Lippincott. Company. Philadelphi., (1994)
  3. CORTI, R., FARKOUH, M.E., & BADIMON, J.J.: The vulnerable plaque and acute coronary syndromes. Am. J. Med., 113, 668-680 (2002) https://doi.org/10.1016/S0002-9343(02)01344-X
  4. CORTI, R., FUSTER, V. & BADIMON, J.J.: Pathogenetic concepts of acute coronary syndromes. J. Am. Coli. Cardiol., 41, 7S-14S (2003) https://doi.org/10.1016/S0735-1097(02)02833-4
  5. FARNDALE, R.W., SIXMA, J.J., BARNES, M.J. & DE, GROOT. P.G.: The role of collagen in thrombosis and hemostasis. J. Thromb. Haemost., 2, 561-573 (2004) https://doi.org/10.1111/j.1538-7836.2004.00665.x
  6. JACKSON, S.P., NESBITI, W.S. & KULKARNI, S.: Signaling events underlying thrombus formation. J. Thromb. Haemost., 1, 1602-1612 (2003) https://doi.org/10.1046/j.1538-7836.2003.00267.x
  7. JIN, Y.R., CHO, M.R., RYU, C.K., CHUNG, J.H., YUK, D.Y., HONG, J.T., LEE, K.S., LEE, J.J., LEE, M.Y, LIM, Y & YUN, YP.: Antiplatelet activity of 178, an antithrombotic agent, is mediated by $TXA_2$ receptor blockade with $TXA_2$ synthase inhibition and suppression of cytosolic $Ca^{2+}$ mobilization. J. Pharmacol. Exp. Ther., in press (2005) https://doi.org/10.1124/jpet.104.073718
  8. KANG, W.S., CHUNG, K.H., CHUNG, J.H., LEE, lY, PARK, J.B., ZHANG, Y.H., YOO, H.S. & YUN, Y.P.: Antiplatelet activity of green tea catechins is mediated by inhibition of cytosolic calcium increase. J. Cardiovasc. Pharmacol., 38, 875-884 (2001) https://doi.org/10.1097/00005344-200112000-00009
  9. KARMAZYN, M.: Role of sodium-hydrogen exchange in cardiac hypertrophy and heart failure: a novel and promising therapeutic target. Basic. Res. Cardiol., 96, 325-328 (2001) https://doi.org/10.1007/s003950170040
  10. KARMAZYN, M., GAN, X.T., HUMPHREYS, R.A., YOSHIDA, H. & KUSUMOTO, K.: The myocardial $Na^+$/$H^+$ exchange: structure, regulation, and its role in heart disease. Circ. Res., 85, 777-786 (1999) https://doi.org/10.1161/01.RES.85.9.777
  11. KIM, H.S., ZHANG, YH. & YUN, YP.: Effects of tetrandrine and fangchinoline on experimental thrombosis in mice and human platelet aggregation. Planta. Med., 65, 135-138 (1999) https://doi.org/10.1055/s-1999-13974
  12. KLINKHARDT, U., KUCZKA, K. & HARDER, S.: Effects of the NHE-I inhibitor cariporide alone or together with the P2YI2 antagonist AR-C 69331 MX on CD62p expression and formation of platelet-leukocyte aggregates. Thromb. Res., 111, 251-257 (2003) https://doi.org/10.1016/j.thromres.2003.09.015
  13. LAPETINA, E.G.: The signal transduction induced by thrombin in human platelets. FEBS. Lett., 268, 400-404 (1990) https://doi.org/10.1016/0014-5793(90)81293-W
  14. MENTZER, R.M.JR, LASLEY, R.D., JESSEL, A. & KARMAZYN, M.: Intracellular sodium hydrogen exchange inhibition and clinical myocardial protection. Ann. Thorac. Surg., 75, S700-S708 (2003) https://doi.org/10.1016/S0003-4975(02)04700-8
  15. PREVOST, N., WOULFE, D., TOGNOLINI, M. & BRASS, L.F.: Contact-dependent signaling during the late events of platelet activation. J. Thromb. Haemost., 1, 1613-1627 (2003) https://doi.org/10.1046/j.1538-7836.2003.00327.x
  16. ROBERTS, D.E., MCNICOL, A & BOSE, R: Mechanism of collagen activation in human platelets. J. Biol. Chem., 279, 19421-19430 (2004) https://doi.org/10.1074/jbc.M308864200
  17. ROSSKOPF, D. Sodium-hydrogen exchange and platelet function. J. Thromb. Thrombolysis., 8, 15-24 (1999) https://doi.org/10.1023/A:1008986329267
  18. RUIZ-MEANA, M., GARCIA-DORADO, D., PINA, P., INSERTE, J, AGULLO, L. & SOLER-SOLER, J.: Cariporide preserves mitochondrial proton gradient and delays ATP depletion in cardiomyocytes during ischemic conditions. Am. J. Physiol. Heart. Circ. physiol., 285, H999-Hl006 (2003) https://doi.org/10.1152/ajpheart.00035.2003
  19. SHAH, RH., NAWAZ, Z., PERTANI, SA, ROOMI, A., MAHMOOD, H., SAEED, S.A. & GILANI, A.H.: Inhibitory effect of curcumin, a food spice from turmeric, on platelet-activating factor- and arachidonic acid-mediated platelet aggregation through inhibition of thromboxane formation and $Ca^{2+}$ signaling. Biochem. Pharmacol., 58, 1167-1172 (1999) https://doi.org/10.1016/S0006-2952(99)00206-3
  20. SIFFERT, w.: Regulation of platelet function by sodium-hydrogen exchange. Cardiovasc. Res., 29, 160-166 (1995) https://doi.org/10.1016/S0008-6363(96)88564-6
  21. STELMACH, H., RUSAK, T. & TOMASIAK, M.: The involvement of the Na(+)/H(+) exchanger in the formation of microvesicles by porcine platelets. Haematologia. (Budap)., 32, 239-252 (2002) https://doi.org/10.1163/15685590260461057
  22. TOURET, N., TANNEUR, V., GODART, H., SEIDLER, R., TAKI, N., BURGER, E., DAMMGEN, J. & COUNILLON, L.: Characterization of sabiporide, a new specific NHE-l inhibitor exhibiting slow dissociation kinetics and cardioprotective effects. Eur. J. Pharmacol., 459, 151-158 (2003) https://doi.org/10.1016/S0014-2999(02)02824-8